Header Logo

Connection

WOLFGANG WINKELMAYER to Adult

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Adult.
WOLFGANG WINKELMAYER
Connection Strength
1.654
Adult
  1. Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018. PLoS One. 2020; 15(12):e0243431.
    View in: PubMed
    Score: 0.043
  2. Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health. Clin J Am Soc Nephrol. 2020 07 01; 15(7):937-948.
    View in: PubMed
    Score: 0.042
  3. Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids. J Am Soc Nephrol. 2020 06; 31(6):1325-1334.
    View in: PubMed
    Score: 0.042
  4. Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014. Transplantation. 2019 11; 103(11):2413-2422.
    View in: PubMed
    Score: 0.040
  5. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
    View in: PubMed
    Score: 0.038
  6. De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis. 2018 08; 72(2):223-233.
    View in: PubMed
    Score: 0.036
  7. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.035
  8. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States. Transplantation. 2017 10; 101(10):2636-2647.
    View in: PubMed
    Score: 0.035
  9. Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplant. 2017 May 01; 32(5):862-869.
    View in: PubMed
    Score: 0.034
  10. Nephrologists' Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):454-466.
    View in: PubMed
    Score: 0.033
  11. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients. Am J Kidney Dis. 2017 May; 69(5):595-601.
    View in: PubMed
    Score: 0.033
  12. Kidney Transplantation Outcomes across GN Subtypes in the United States. J Am Soc Nephrol. 2017 02; 28(2):632-644.
    View in: PubMed
    Score: 0.032
  13. Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States. Am J Kidney Dis. 2016 Apr; 67(4):638-47.
    View in: PubMed
    Score: 0.031
  14. Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease. BMC Nephrol. 2015 Dec 09; 16:204.
    View in: PubMed
    Score: 0.031
  15. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
    View in: PubMed
    Score: 0.031
  16. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2015 Oct; 30(10):1734-40.
    View in: PubMed
    Score: 0.030
  17. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.030
  18. Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant. 2015 Feb; 15(2):499-507.
    View in: PubMed
    Score: 0.029
  19. Perspectives on pregnancy in women with chronic kidney disease: systematic review of qualitative studies. Nephrol Dial Transplant. 2015 Apr; 30(4):652-61.
    View in: PubMed
    Score: 0.029
  20. State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol. 2014 Jun; 25(6):1321-9.
    View in: PubMed
    Score: 0.027
  21. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
    View in: PubMed
    Score: 0.027
  22. Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
    View in: PubMed
    Score: 0.026
  23. Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. Am J Kidney Dis. 2013 Aug; 62(2):312-21.
    View in: PubMed
    Score: 0.026
  24. Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol. 2013 Apr 26; 14:97.
    View in: PubMed
    Score: 0.026
  25. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013 Mar-Apr; 33(2):155-66.
    View in: PubMed
    Score: 0.025
  26. Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
    View in: PubMed
    Score: 0.024
  27. Altitude and the risk of cardiovascular events in incident US dialysis patients. Nephrol Dial Transplant. 2012 Jun; 27(6):2411-7.
    View in: PubMed
    Score: 0.023
  28. Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol. 2012 Feb; 7(2):289-96.
    View in: PubMed
    Score: 0.023
  29. Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J. 2011 Aug; 162(2):324-30.
    View in: PubMed
    Score: 0.023
  30. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17.
    View in: PubMed
    Score: 0.022
  31. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011 Feb; 22(2):349-57.
    View in: PubMed
    Score: 0.022
  32. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):57-65.
    View in: PubMed
    Score: 0.022
  33. Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clin J Am Soc Nephrol. 2011 Jan; 6(1):175-83.
    View in: PubMed
    Score: 0.021
  34. ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mellitus: are they underutilized? Drugs Aging. 2010 Feb 01; 27(2):87-94.
    View in: PubMed
    Score: 0.020
  35. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul; 19(7):1389-95.
    View in: PubMed
    Score: 0.018
  36. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int. 2007 Dec; 72(11):1388-93.
    View in: PubMed
    Score: 0.017
  37. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11.
    View in: PubMed
    Score: 0.017
  38. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007 Jan; 71(2):153-8.
    View in: PubMed
    Score: 0.016
  39. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int. 2005 Dec; 68(6):2857-62.
    View in: PubMed
    Score: 0.015
  40. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int. 2005 May; 67(5):1980-5.
    View in: PubMed
    Score: 0.015
  41. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan; 16(1):255-60.
    View in: PubMed
    Score: 0.014
  42. Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States. Am J Kidney Dis. 2025 Mar; 85(3):273-283.e1.
    View in: PubMed
    Score: 0.014
  43. Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
    View in: PubMed
    Score: 0.014
  44. C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. Am J Transplant. 2004 Jul; 4(7):1148-54.
    View in: PubMed
    Score: 0.014
  45. Effects of TCN2 776C>G on vitamin B, folate, and total homocysteine levels in kidney transplant patients. Kidney Int. 2004 May; 65(5):1877-81.
    View in: PubMed
    Score: 0.014
  46. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
    View in: PubMed
    Score: 0.014
  47. Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis. 2004 May; 174(1):43-8.
    View in: PubMed
    Score: 0.014
  48. Hetastarch and bleeding complications after coronary artery surgery. Chest. 2003 Oct; 124(4):1437-42.
    View in: PubMed
    Score: 0.013
  49. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
    View in: PubMed
    Score: 0.013
  50. Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int. 2003 Jun; 63(6):2280-5.
    View in: PubMed
    Score: 0.013
  51. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
    Score: 0.012
  52. Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study. Pediatr Nephrol. 2023 01; 38(1):249-260.
    View in: PubMed
    Score: 0.012
  53. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 06; 31(6):670-679.
    View in: PubMed
    Score: 0.012
  54. Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials. Nephrol Dial Transplant. 2021 11 09; 36(11):2039-2048.
    View in: PubMed
    Score: 0.012
  55. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
    Score: 0.011
  56. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136.
    View in: PubMed
    Score: 0.011
  57. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020 10 01; 35(10):1761-1769.
    View in: PubMed
    Score: 0.011
  58. Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks-A Narrative Review. Mayo Clin Proc. 2020 10; 95(10):2204-2224.
    View in: PubMed
    Score: 0.011
  59. Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study. Am J Kidney Dis. 2020 11; 76(5):679-689.
    View in: PubMed
    Score: 0.010
  60. Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis. Sci Rep. 2020 05 18; 10(1):8140.
    View in: PubMed
    Score: 0.010
  61. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study. Sci Rep. 2020 04 06; 10(1):5964.
    View in: PubMed
    Score: 0.010
  62. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.010
  63. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
    View in: PubMed
    Score: 0.010
  64. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.010
  65. Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
    View in: PubMed
    Score: 0.010
  66. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.010
  67. Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Netw Open. 2019 05 03; 2(5):e193987.
    View in: PubMed
    Score: 0.010
  68. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
    View in: PubMed
    Score: 0.009
  69. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.009
  70. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis. Int J Cardiol. 2019 05 15; 283:165-170.
    View in: PubMed
    Score: 0.009
  71. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.009
  72. Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review. Am J Kidney Dis. 2018 07; 72(1):62-74.
    View in: PubMed
    Score: 0.009
  73. Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD. Clin J Am Soc Nephrol. 2017 Nov 07; 12(11):1778-1786.
    View in: PubMed
    Score: 0.009
  74. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis. 2017 Oct; 70(4):464-475.
    View in: PubMed
    Score: 0.008
  75. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications. Arthritis Rheumatol. 2017 02; 69(2):387-397.
    View in: PubMed
    Score: 0.008
  76. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. J Cardiovasc Electrophysiol. 2017 01; 28(1):39-48.
    View in: PubMed
    Score: 0.008
  77. The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients. Clin Lab. 2016 Oct 01; 62(10):1965-1972.
    View in: PubMed
    Score: 0.008
  78. Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis. 2016 09; 68(3):414-21.
    View in: PubMed
    Score: 0.008
  79. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis. 2016 Sep; 68(3):444-54.
    View in: PubMed
    Score: 0.008
  80. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. 2016 05; 16(5):1492-502.
    View in: PubMed
    Score: 0.008
  81. A Cost Analysis of Tolerance Induction for Two-Haplotype Match Kidney Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):371-3.
    View in: PubMed
    Score: 0.008
  82. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
    View in: PubMed
    Score: 0.008
  83. Perspectives on Pregnancy in Women With CKD: A Semistructured Interview Study. Am J Kidney Dis. 2015 Dec; 66(6):951-61.
    View in: PubMed
    Score: 0.008
  84. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis. Arthritis Care Res (Hoboken). 2015 Oct; 67(10):1453-62.
    View in: PubMed
    Score: 0.008
  85. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol. 2015 Jun; 67(6):1577-85.
    View in: PubMed
    Score: 0.007
  86. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.007
  87. Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation. 2013 Jun 15; 95(11):1338-45.
    View in: PubMed
    Score: 0.006
  88. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013 Mar; 65(3):753-63.
    View in: PubMed
    Score: 0.006
  89. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
    View in: PubMed
    Score: 0.006
  90. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
    View in: PubMed
    Score: 0.006
  91. Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant. 2012 Jan; 27(1):429-34.
    View in: PubMed
    Score: 0.006
  92. Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Card Fail. 2011 Jul; 17(7):533-9.
    View in: PubMed
    Score: 0.006
  93. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival. BMC Nephrol. 2010 Apr 01; 11:5.
    View in: PubMed
    Score: 0.005
  94. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation. 2009 Dec 27; 88(12):1377-85.
    View in: PubMed
    Score: 0.005
  95. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6.
    View in: PubMed
    Score: 0.004
  96. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int. 2007 Mar; 20(3):247-55.
    View in: PubMed
    Score: 0.004
  97. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
    View in: PubMed
    Score: 0.004
  98. The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis. 2005 Aug 01; 41(3):301-7.
    View in: PubMed
    Score: 0.004
  99. Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant. 2004 Aug; 18(4):341-8.
    View in: PubMed
    Score: 0.003
  100. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.003
  101. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.